3Lai KN. Membranous nephropathy: When and how to treat. Kidney Int,2007,71(9) :841 - 843.
4Schieppati A, Pema A, Zamora J, et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev, 2004, 18(4) : CD004293.
5Ponticelli C, Passerini P, Salvadori M, et al. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrcnocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis,2006,47(2) :233 - 240.
6Jha V, Ganguli A, Saha TK, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syn- drome caused by idiopathic membranous nephropathy. J Am Soc Nephrol,2007,18(6) :1899 - 1904.
7du Bur - Vereijken PW, Branten AJ, Wetzels JF. Idiopathic membranous nephropathy:outline and rationale of a treatment strategy. Am J Kid Dis, 2005,46(6):1012 - 1029.
8Goumenos DS, Katopodis KP, Passadakis P, et al. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol,2007,27(3):226 - 231.
9Alexopoulos E, Papagianni A, Tsamelashvili M, et al. Induction and long- term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant,2006,21(11) :3127-3132.
10Cattran DC. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol, 2005,16 (5) : 1188 - 1194.
